PCM
AIMT

Penserra Capital Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Penserra Capital Management’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-560
Closed -$19K – 1165
2020
Q3 		$19K Buy
+560
New +$19K ﹤0.01% 751